1. Home
  2. GBIO vs DSP Comparison

GBIO vs DSP Comparison

Compare GBIO & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • DSP
  • Stock Information
  • Founded
  • GBIO 2016
  • DSP 1999
  • Country
  • GBIO United States
  • DSP United States
  • Employees
  • GBIO N/A
  • DSP N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • DSP EDP Services
  • Sector
  • GBIO Health Care
  • DSP Technology
  • Exchange
  • GBIO Nasdaq
  • DSP Nasdaq
  • Market Cap
  • GBIO 29.5M
  • DSP 220.3M
  • IPO Year
  • GBIO 2020
  • DSP 2021
  • Fundamental
  • Price
  • GBIO $5.60
  • DSP $9.39
  • Analyst Decision
  • GBIO Buy
  • DSP Strong Buy
  • Analyst Count
  • GBIO 4
  • DSP 9
  • Target Price
  • GBIO $10.67
  • DSP $20.44
  • AVG Volume (30 Days)
  • GBIO 85.8K
  • DSP 253.4K
  • Earning Date
  • GBIO 11-05-2025
  • DSP 11-11-2025
  • Dividend Yield
  • GBIO N/A
  • DSP N/A
  • EPS Growth
  • GBIO N/A
  • DSP N/A
  • EPS
  • GBIO N/A
  • DSP 0.13
  • Revenue
  • GBIO $21,230,000.00
  • DSP $318,471,000.00
  • Revenue This Year
  • GBIO N/A
  • DSP $16.44
  • Revenue Next Year
  • GBIO N/A
  • DSP $15.32
  • P/E Ratio
  • GBIO N/A
  • DSP $72.82
  • Revenue Growth
  • GBIO 61.15
  • DSP 30.92
  • 52 Week Low
  • GBIO $3.00
  • DSP $9.07
  • 52 Week High
  • GBIO $29.10
  • DSP $26.33
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 47.90
  • DSP 34.85
  • Support Level
  • GBIO $5.63
  • DSP $9.63
  • Resistance Level
  • GBIO $6.25
  • DSP $10.15
  • Average True Range (ATR)
  • GBIO 0.32
  • DSP 0.37
  • MACD
  • GBIO -0.11
  • DSP 0.07
  • Stochastic Oscillator
  • GBIO 8.33
  • DSP 0.00

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About DSP Viant Technology Inc.

Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.

Share on Social Networks: